Dr. Christiansen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
2255 Ygnacio Valley Road
Suite M
Walnut Creek, CA 94598Phone+1 925-930-7267- Is this information wrong?
Education & Training
- University of California (San Francisco)Fellowship, Endocrinology, Diabetes, and Metabolism, 1988 - 1990
- Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Internal Medicine, 1985 - 1988
- Case Western Reserve University School of MedicineClass of 1985
Certifications & Licensure
- CA State Medical License 1988 - 2025
- American Board of Internal Medicine Internal Medicine
Clinical Trials
- Safety and Efficacy of Intranasal TBS-1 Treatment of Male Hypogonadism Start of enrollment: 2011 Sep 01
- A Performance Evaluation of the Enlite Glucose Sensor to Support a Full 144 Hours(6Days) of Use Start of enrollment: 2011 Nov 01
Publications & Presentations
PubMed
- 91 citationsSafety and Glycemic Outcomes During the MiniMed™ Advanced Hybrid Closed-Loop System Pivotal Trial in Adolescents and Adults with Type 1 Diabetes.Anders L. Carlson, Jennifer L. Sherr, Dorothy I. Shulman, Satish K. Garg, Rodica Pop-Busui, Bruce W. Bode, David R. Lilenquist, Ron Brazg, Kevin B. Kaiserman, Mark Kip...> ;Diabetes Technology & Therapeutics. 2021 Nov 16
- 12 citationsComparison of a ready-to-use liquid glucagon injection administered by autoinjector to glucagon emergency kit for the symptomatic relief of severe hypoglycemia: two ra...Mark P. Christiansen, Martin J. Cummins, Steven J. Prestrelski, Nicole C. Close, Anh Nguyen, Khaled Junaidi> ;BMJ Open Diabetes Research & Care. 2021 Oct 1
- 33 citationsEvaluation of Accuracy and Safety of the Next-Generation Up to 180-Day Long-Term Implantable Eversense Continuous Glucose Monitoring System: The PROMISE Study.Satish K. Garg, David R. Liljenquist, Bruce W. Bode, Mark P. Christiansen, Timothy S. Bailey, Ronald L. Brazg, Douglas S Denham, Anna R Chang, Halis Kaan Akturk, Andre...> ;Diabetes Technology & Therapeutics. 2021 Sep 9
- Join now to see all
Press Mentions
- Abbott, Medtronic Go Head-to-Head at ADA ConferenceJune 15th, 2020
- Senseonics Announces First Study Participant Implanted in the U.S. As Part of the PROMISE 180-Day Sensor Clinical Study and the Submission of Key PMA Supplements to the FDA to Advance Current 90-Day ProductJanuary 3rd, 2019
- Senseonics Maakt Uitstekende Nauwkeurigheidsresultaten Bekend Uit Hoofdstudie Eversense CGM-Systeem in VSAugust 10th, 2016
- Join now to see all
Grant Support
- Hepatic Insulin Resistance Associated With The Use Of PINational Center For Research Resources2000–2002
- Effects Of Etiocholanedione On Hepatic Metabolism &Insulin ResistancNational Center For Research Resources1999–2002
Professional Memberships
- Member
Hospital Affiliations
- John Muir Medical Center, Walnut CreekWalnut Creek, California
- Stanford Health Care Tri-ValleyPleasanton, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: